뒤로
Simcere Pharmaceutical Group Limited(02096.HK) 가격
02096.HK 주가 차트
SIMCERE PHARMA (02096.HK)
Simcere Pharmaceutical Group Limited
HK$11.64
0.17%
$0.02
장 종료: Jan 16, 16:00:00 HKT
아직 데이터 없음Earnings FAQ
02096.HK의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Simcere Pharmaceutical Group Limited 02096.HK의 지난 분기 매출 실적은 어땠나요?
Simcere Pharmaceutical Group Limited의 매출 추정치는 얼마인가요?
Simcere Pharmaceutical Group Limited의 수익 품질 점수는 얼마인가요?
Simcere Pharmaceutical Group Limited는 언제 수익을 보고하나요?
Simcere Pharmaceutical Group Limited의 예상 수익은 얼마인가요?
Simcere Pharmaceutical Group Limited은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$11.62
시가
$11.62
일일 범위
$11.44 - $11.78
52주 범위
$6.2 - $15.08
거래량
11.0M
평균 거래량
8.2M
EPS(TTM)
0.40
배당수익률
--
시가총액
$30.2B
SIMCERE PHARMA란 무엇인가요?
Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 6,815 full-time employees. The company went IPO on 2020-10-27. The firm's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The firm also produces various drugs, including Endostar used for oncology. The firm is also involved in providing promotion services for third-party drugs sold by medical institutions. The firm mainly conducts its businesses in the domestic market and overseas markets.